The gene-therapy trial aims to treat glaucoma by rejuvenating cells in the optic nerve. Plus, the mystery of how things freeze and encouragement to go out into the sunlight.
09 June 2026
The gene-therapy trial aims to treat glaucoma by rejuvenating cells in the optic nerve. Plus, the mystery of how things freeze and encouragement to go out into the sunlight.
By
Flora Graham
You have full access to this article via your institution.
The first participant has been treated in a landmark clinical trial of cellular reprogramming, which aims to rejuvenate ageing…
An eagerly awaited and controversial clinical trial to 'wind back the clock' on aging cells in the eye and restore them to a more…
A US biotechnology company has tested a gene therapy designed to reverse ageing in humans for the first time.
El avance, destacado por el especialista en longevidad Eric Topol, marca el inicio de un ensayo en Estados Unidos donde se busca…
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
Life Biosciences will test its gene therapy designed to partially reset a cell’s age and reverse vision loss in patients with…
La primera terapia genética para rejuvenecer células humanas inicia pruebas en pacientes con glaucoma
